On February 20, 2019, according to the Shenzhen Market Supervision and Administration Bureau [2019] No. 41 document, Shenzhen Beike Biotechnology Co., Ltd. (hereinafter referred to as: Beike Biotechnology) won the “Synchronized R&D and Standardization Demonstration Enterprise”title.
This honor represents the recognition of Beike Biotech in the research and development and standardization direction by various municipal departments. marks that Beike Biotechnology, as a leading company in the cell technology industry, has added a new step towards industry standardization!
“R&D and Standardization Simultaneous Demonstration Enterprise” review has been carried out for two consecutive years since 2017.Established in accordance with the deployment of the municipal government’s “Shenzhen Standard Internationalized Innovative City Demonstration Creation Work Plan” and the standard requirements of the “R&D and Standardization Simultaneous Demonstration Enterprise Evaluation Guide”, is an important link in creating Shenzhen quality and Shenzhen standards. It aims to evaluate the effectiveness of the simultaneous construction of enterprise R&D and standardization, cultivate and identify a group of demonstration enterprises for the simultaneous construction of R&D and standardization, and give full play to the role of benchmark enterprises. baseline;”>Demonstrate the leading effect.
Cell preparation technology is a complex high-tech, and standardization work is relatively weak. Beike Biotechnology, as a pathfinder in this field, has been committed to the development of industry standardization:
In 2011, Beike Biotech overcame many difficulties and took the lead in introducing international AABB certification;
In 2016, Beike Biotech took the lead in drafting and compiling Shenzhen local standards: “Cell Preparation Center Construction and Management Specifications” and “Comprehensive Cell Bank Setup and Management Specifications”;
In 2016, Beike Biotech participated in the formulation of the “Self-Discipline Specification for Quality Management of Stem Cell Preparation Preparation” and “Self-Regulatory Specification for Quality Management of Immune Cell Preparation Preparation”;
In 2018, Beike Biotech was the first to apply for the title of “Cell Preparation Engineer” from the Bureau of Human Resources and Social Security;
In 2018, Beike Biotech took the lead in introducing third-party quality inspection.
……
Beike Biotechnology is an early national high-tech enterprise specializing in the clinical transformation and technical services of biotherapeutic technologies in strategic emerging industries in my country. It attaches great importance to research and development and standardization management, and promotes and ensures the simultaneous development of technology research and development, standard innovation, and industrialization from aspects such as organizational structure, budget, and management systems.
This time, Beike Biotech successfully won the title of “Synchronized R&D and Standardization Demonstration Enterprise” after going through self-evaluation, application, defense, expert review and social publicity.It is the recognition of the municipal government and society for the standardization and R&D work of Beike Biology!
Beike Biotechnology, as a pathfinder in this field, will continue to increase investment in R&D and standardization construction, promote more efficient development of enterprises, bring better services to users, and contribute more to the standardization construction of the country and industry!